Rhythm Pharmaceuticals, Inc..
RYTM.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for rare genetic diseases of obesity. The company's lead product, IMCIVREE (setmelanotide), is a melanocortin-4 receptor (MC4R) agonist approved for chronic weight managem...Show More
Better Health for All
0
No evidence available to assess Rhythm Pharmaceuticals, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess Rhythm Pharmaceuticals, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
30
In 2024, the CEO-to-median employee pay ratio was approximately 36 to 1.
1
The company's employee turnover rate was 11% in 2024.
2
Rhythm Pharmaceuticals offers all full-time employees health and welfare plans, including medical, dental, and vision benefits, with 100% of employees eligible for these benefits, including dependents and mental health services.
3
The company has no public record of labor-law breaches or substantiated labor-law or human-rights violations in the past three years. Rhythm Pharmaceuticals had 302 employees as of April 29, 2025.
4
The company maintains a 401(k) retirement savings plan for U.S. employees with matching contributions and provides an Employee Stock Purchase Plan.
5
It condemns all forms of modern slavery, child labor, and human trafficking, and has an anti-discrimination policy, incident notification, confidentiality mechanisms, and retaliation safeguards in place for handling harassment and discrimination.
6
Fair Trade & Ethical Sourcing
0
No specific, quantitative data points were found in the provided articles regarding Rhythm Pharmaceuticals, Inc.'s (RYTM.US) fair trade and ethical sourcing practices. The articles discuss the general importance of supplier audits in the pharmaceutical industry and the company's compliance program related to marketing to healthcare professionals, but do not provide information on fair trade certifications, audit frequency, forced/child labor incidents, supply chain traceability, remediation speed, ethical clause coverage, materials risk, or supplier diversity spend for RYTM.US.
1
Honest & Fair Business
0
No evidence available to assess Rhythm Pharmaceuticals, Inc. on Honest & Fair Business.
Kind to Animals
0
No specific, quantitative evidence was found in the provided articles for Rhythm Pharmaceuticals regarding any of the 'Kind to Animals' KPIs. While one article (Article 3) confirmed that extensive preclinical studies involving rats and monkeys were conducted for their product, setmelanotide, it did not provide specific data on the volume of animals used, the extent of non-animal testing methods employed, or the company's animal testing policy.
1
Rhythm Pharmaceuticals' 2023 Sustainability Report (Article 2) explicitly stated that it 'does not explicitly state an animal testing policy' and provided 'no specific data on animal testing volume.'
2
It also provided the total R&D expenses but not the percentage allocated to animal-free innovation.
3
Information about other companies' animal welfare practices (Article 0) is not applicable to Rhythm Pharmaceuticals. Therefore, all KPIs related to animal welfare are omitted due to a lack of explicit, scorable evidence for Rhythm Pharmaceuticals.
No War, No Weapons
0
Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company focused on drug development and genetic sequencing, with no direct involvement in arms or defense activities.
1
The company's core business does not generate revenue from arms or defense contracts, nor does it develop or sell dual-use technologies with military applications.
2
There is no evidence of exposure to controversial or banned weapons, and no involvement in AI systems with potential military uses or intelligence/surveillance contracts.
3
The company's Code of Business Conduct and Ethics guides employees, indicating ethical red lines are codified within its operational framework.
4
Furthermore, the company reported 100% compliance with ethical standards in its core business operations, with no reported incidents of corruption in 2022, 2023, or so far in 2024.
5
Planet-Friendly Business
0
No evidence available to assess Rhythm Pharmaceuticals, Inc. on Planet-Friendly Business.
Respect for Cultures & Communities
0
No evidence available to assess Rhythm Pharmaceuticals, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
-30
Rhythm Pharmaceuticals provides users with rights to information, deletion, correction, data transferability, objection to processing, and withdrawal of consent, which can be exercised via email.
1
The company states that data is retained only as long as necessary for the purpose of collection or as legally required.
2
The company explicitly states compliance with GDPR and applicable laws, including CCPA.
3
Additionally, Rhythm Pharmaceuticals' policy states that data sales are not permitted.
4
Zero Waste & Sustainable Products
0
No evidence available to assess Rhythm Pharmaceuticals, Inc. on Zero Waste & Sustainable Products.